Frontlight ResearchEarly access
Melanoma trials in United States
223 of 268 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 120
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT07040280 - Phase 3Taking peopleComparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Where
- Albuquerque, Anaconda, Arroyo Grande, Atlanta, Aurora, Avon, Bardstown, Baton Rouge, Battle Creek, Beachwood, Bemidji, Berlin Corners, Billings, Birmingham, Bismarck, Bozeman, Bridgeport, Buffalo, Burlington, Burr Ridge, Carmichael, Cary, Chadds Ford, Charleston, Charlottesville, Cheyenne, Chicago, Cincinnati, Cleveland, Cody, Coeur d'Alene, Colorado Springs, Columbus, Corbin, Daphne, Durango, Durham, East Norriton, Elk Grove, Elkton, Erie, Evanston, Fairbanks, Fairhope, Fargo, Glens Falls, Glenview, Grand Island, Grand Rapids, Great Falls, Hackensack, Hackettstown, Havre, Helena, Highland Park, Homer Glen, Irvine, Kalamazoo, Kalispell, Kansas City, Kearney, La Jolla, Lake Forest, Lakeland, Lake Mary, Lakewood, Lee's Summit, Lewes, Lexington, Loma Linda, London, Long Branch, Longmont, Los Angeles, Marshfield, Martinsburg, Maywood, Melrose Park, Menomonee Falls, Merced, Millville, Milwaukee, Mineola, Missoula, Mobile, Morgantown, Morristown, Mount Sterling, Muskegon, Nashville, Newark, New Berlin, New Brunswick, Newton, New York, Niles, Norton Shores, Oak Creek, Ocoee, Oklahoma City, Omaha, Orange, Orlando, Orland Park, Overland Park, Paramus, Parkersburg, Patchogue, Philadelphia, Phoenix, Pittsburgh, Pompton, Post Falls, Princeton, Pueblo, Raleigh, Reed City, Rehoboth Beach, Reno, Richmond, Rocklin, Sacramento, Saint Joseph, Sandpoint, San Luis Obispo, Santa Maria, Saraland, Seattle, Silverdale, Stockton, Stony Brook, Summit, The Bronx, Thief River Falls, Toms River, Traverse City, West Bend, Westminster, Weston, Westwood, Willow Grove, Wilmington, Woodland, Wyoming
- Age
- 75 years and over
- People
- 428
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT07068074 - No phaseNot yet taking people in United StatesSkin Cancer Detection in Primary Care With and Without DermaSensor
- Where
- St Louis
- People
- 200
- Run by
- DermaSensor, Inc.
See details and how to joinNCT07940036 - Phase 1/2Taking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Aurora, Boston, Chicago, Dallas, Fargo, New York, Sioux Falls
- Age
- 6 months to 17 years
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - Phase 1Taking peopleA Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Where
- Ann Arbor, Cleveland, Fairfax, Houston, Portland
- Age
- 18 years and over
- People
- 67
- Run by
- Novelty Nobility, Inc.
See details and how to joinNCT06805825 - Phase 2Taking peopleEffects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 86
- Run by
- University of Utah
See details and how to joinNCT04844528 - No phaseTaking peopleHigh Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
- Where
- Houston
- Age
- 19 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05053555 - Phase 2Taking peopleBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Where
- ‘Aiea, Albuquerque, Alexandria, Ames, Anaconda, Ankeny, Ann Arbor, Ashland, Aurora, Battle Creek, Bellevue, Bemidji, Bend, Beverly Hills, Billings, Bismarck, Bloomington, Boise, Boone, Boston, Bozeman, Brainerd, Brighton, Burnsville, Caldwell, Canton, Cape Girardeau, Carthage, Cedar Rapids, Centerville, Centralia, Chaska, Chelsea, Chicago, City of Saint Peters, Clackamas, Clinton, Clive, Coeur d'Alene, Colorado Springs, Coon Rapids, Creve Coeur, Danville, Dayton, Decatur, Deer River, DeKalb, Des Moines, Detroit, Detroit Lakes, Dixon, Duluth, Eau Claire, Edina, Effingham, Escanaba, Eureka, Fairfax, Falls Church, Fargo, Farmington Hills, Flint, Fort Collins, Fort Dodge, Fosston, Franklin, Fridley, Fruitland, Galesburg, Geneva, Glenview, Goldsboro, Grand Rapids, Grayslake, Great Falls, Greeley, Green Bay, Greenville, Hibbing, Honolulu, Irvine, Jacksonville, Jamestown, Jefferson, Kalamazoo, Kalispell, Kewanee, La Crosse, Lake Forest, Lake Success, Lansing, Lebanon, Little Rock, Livonia, Los Angeles, Loveland, Lynchburg, Macomb, Maplewood, Marshalltown, Marshfield, Mattoon, Maywood, Meridian, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Mukwonago, Muskegon, Nampa, Newark, Newberg, New Richmond, New York, Niles, Normal, Norton Shores, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orlando, Orland Park, Ottawa, Park Rapids, Pekin, Peoria, Peru, Philadelphia, Phoenix, Pontiac, Portland, Post Falls, Princeton, Rapid City, Reed City, Rice Lake, Richmond, Rochester, Saint Johnsbury, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, Sheboygan, Shiloh, Sioux Falls, Springfield, Stevens Point, St Louis, Stoneham, Sturgeon Bay, Superior, Tappahannock, Traverse City, Troy, Twin Falls, Urbana, Virginia, Waconia, Warrenville, Washington, Waukee, Waukesha, Weston, Willow Grove, Woodbury, Wyoming, Yorkville, Ypsilanti
- Age
- 18 years and over
- People
- 150
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05136196 - Phase 2Taking peoplePhase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 78
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05155033 - Phase 1Taking peopleA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Where
- Atlanta, Austin, East Brunswick, Edmonds, Fairfax, Fort Worth, Grand Rapids, Houston, Lake Success, Nashville, New Brunswick, New Haven, San Antonio, Sioux Falls, St Louis, Washington D.C., West Valley City, Wilson
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Pliant Therapeutics, Inc.
See details and how to joinNCT06270706 - Phase 1Taking peopleA Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Where
- Atlanta, Detroit, Houston, Minneapolis, San Francisco
- Age
- 18 years and over
- People
- 30
- Run by
- Outpace Bio, Inc.
See details and how to joinNCT07664735 - Phase 3Taking peopleStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Where
- Boston, Cleveland, Dallas, Grand Rapids, Houston, Los Angeles, Madison, Miami, Nashville, New York, Philadelphia, Raleigh, San Diego, San Francisco, Scottsdale, Tampa
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07804186 - Phase 1Taking peopleStudy of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- Where
- Houston
- Age
- 12 years to 50 years
- People
- 44
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03093909 - Phase 4Active, not recruitingDabrafenib and/or Trametinib Rollover Study
- Where
- Bethesda, Columbus, Dallas, Scottsdale
- Age
- 18 years to 100 years
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - No phaseTaking peopleLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- Where
- Houston
- Age
- 18 years and over
- People
- 252
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03941756 - Phase 1Taking peopleA Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06066138 - Phase 1Taking peopleBlood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)
- Where
- Washington D.C.
- Age
- 3 years to 25 years
- People
- 45
- Run by
- Children's National Research Institute
See details and how to joinNCT07796061 - Phase 2Taking peopleAdjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring
- Where
- Tampa
- Age
- 18 years and over
- People
- 56
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT07930182 - Phase 1/2Taking peopleStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Where
- Allentown, Atlanta, Billings, Camden, Chicago, Clermont, Cleveland, Dallas, Detroit, Duarte, El Paso, Fairfax, Glendale, Grand Island, Grand Rapids, Iowa City, Knoxville, La Jolla, Lakewood, Los Angeles, Louisville, Milwaukee, Murrieta, Nashville, Omaha, Orange City, Portland, Saint Louis Park, Saint Paul, San Antonio, Santa Rosa, St Louis, The Bronx, The Woodlands, Tyler
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT04198766 - Phase 1Taking peopleA Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
- Where
- Durham
- Age
- 18 years and over
- People
- 25
- Run by
- Duke University
See details and how to joinNCT05077137 - Phase 2Taking peopleAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Where
- Grand Forks, Jacksonville
- Age
- 18 years and over
- People
- 220
- Run by
- Mayo Clinic
See details and how to joinNCT05969860 - Phase 3Taking peopleA Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Where
- Albany, Ann Arbor, Asheville, Athens, Aurora, Austin, Baton Rouge, Bedford, Billings, Chandler, Charlotte, Charlottesville, Chattanooga, Cincinnati, Clermont, Cleveland, Coeur d'Alene, Columbia, Columbus, Dallas, Detroit, Durham, Easton, Edmonds, Englewood, Eugene, Fairfax, Fort Collins, Fort Wayne, Fort Worth, Fridley, Fullerton, Gilbert, Grapevine, Greenville, Hackensack, Harlingen, Hershey, Hinsdale, Houston, Issaquah, Jacksonville, Kennewick, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Longview, Los Alamitos, Los Angeles, Lubbock, Madison, McAllen, Minneapolis, Morgantown, Nashville, New Brunswick, New Haven, Norfolk, Omaha, Orange, Palestine, Paramus, Park Ridge, Peoria, Philadelphia, Pittsburgh, Portland, Providence, Rancho Mirage, Redlands, Richmond, Roanoke, Sacramento, Salt Lake City, San Francisco, Santa Barbara, Santa Monica, Seattle, St Louis, Tamarac, Tampa, Tucson, Tulsa, Tyler, Weslaco, Westwood, Wilmington
- Age
- 18 years and over
- People
- 560 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06246916 - Phase 1Taking peopleIL-17 Blockade to Decrease irAEs (REPLAY)
- Where
- Durham
- Age
- 18 years and over
- People
- 4
- Run by
- Duke University
See details and how to joinNCT07237594 - Phase 1Taking peoplePhase 1 Study of PF-08046033 in Advanced Solid Tumors
- Where
- Denver, Fairfax, Nashville, New Haven, Trumbull
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Pfizer
See details and how to joinNCT07519655 - Phase 2Taking peoplePositron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
- Where
- Duarte, Irvine
- Age
- 18 years and over
- People
- 32
- Run by
- City of Hope Medical Center
See details and how to joinNCT05830058